|
CN104726415A
|
|
Method for isolating and culturing serum duck hepatitis A virus-3 through chick embryo
|
|
CN104726414A
|
|
Serum type 3 duck hepatitis A virus live vaccine and preparation method thereof
|
|
CN103484411A
|
|
Avian Escherichia coli vaccine strain (NN strain) and application thereof
|
|
CN103495160A
|
|
Preparation method of inactivated mycoplasma synoviae vaccine
|
|
CN103479995A
|
|
Preparation method of mycoplasma gallisepticum and mycoplasma synoviae bivalent inactivated vaccine
|
|
CN103497934A
|
|
Avian infectious bronchitis virus vaccine strain (HF2 strain) and application thereof
|
|
CN103417980A
|
|
Novel freeze-drying protective additive for duck virus hepatitis live vaccines
|
|
CN103060262A
|
|
Process for producing high-efficiency porcine pseudorabies live vaccine by using STC cell
|
|
CN103060220A
|
|
Low-serum culture medium for efficiently culturing mycoplasma hyopneumoniae and preparation method thereof
|
|
CN103074246A
|
|
Low serum efficiency mycoplasma gallisepticam attenuated strain culture medium and preparation method thereof
|
|
CN103060221A
|
|
Culture medium adopting continuous enrichment culture for mycoplasma gaujseptium and preparation method
|
|
CN103091484A
|
|
Efficacy test method of mycoplasma gallisepticum inactivated vaccine and application thereof
|
